The medications that are used in Mesotherapy melt the fat beneath the skin and shrink the fat cells in the Scarpa’s fascia layer. The fat dissolves and is excreted by the kidneys and the bowel without any changes in your bowel habits.
Cellulite is caused by connective tissue bands that hold down the skin, trapping the fat and thereby causing the “dimpling” effect. The medications used in Mesotherapy destroy the connective tissue bands and melt the trapped fat, creating a smooth, dimple-free appearance. In Mesotherapy, very small doses of different medications are administered in specific areas, depending on the condition being treated. The medicines and plant extracts that we use at Mesotherapy Associates, P.C. are obtained from local pharmaceutical companies in the United States . All medicines used are FDA-approved for their use. In combination, medicines for Mesotherapy are used for off-line purposes. A recent illustration of this distinction is Botox. Although Botox is FDA approved for controlling muscle spasms, the medical community embraced it for its cosmetic propberties of controlling wrinkles. For many years, plastic surgeons and dermatologists have used Botox for off-line purposes….. Read more…

Mesotherapy is a technique, invented in 1952 by Dr. Michel Pistor, where medication is injected into the mesoderm, the layer of fat and connective tissue under the skin. Over the past 50+ years, an excess of 15,000 physicians world-wide have used Mesotherapy on a daily basis for a variety of purposes, including overall weight loss, spot weight reduction, cellulite reduction, hair loss, scar revision and wrinkle elimination. Mesotherapy is also used to correct unevenness, lumps, or divots that develop after liposuction. In 1987, the French Academy of Medicine recognized Mesotherapy as an inherent part of traditional medicine. The International Society of Mesotherapy encompasses 14 countries throughout Europe and South America. Using a very tiny needle (0.4 to 0.6 cm or the size of an eyelash), the medication is injected into the mesoderm painlessly. Sometimes the technique of “multi-pricking” is used, where a number of swift, painless injections are concentrated in a specific area. Although “multi-pricking” can be done by hand, we at Mesotherapy Associates offer a mechanical delivery system that delivers the medicine in a more accurate fashion with even less discomfort to the patient. Patients have universally reported that the treatments cause less pain than a momentary, light pinch.

Dallas, TX: It is the need of the day, mesothelioma cancer patients and patients with other forms of cancers too need drugs that could pull them out of the misery they are in. Anti Angiogenesis drugs have rising the hope of survival and recovery of the cancer patients.
Angiogenesis process is explained as:
Angiogenesis is a process that involves the growth of new blood vessels from the existing ones. Angiogenesis, is therefore a normal process in the growth and development of the blood capillaries and vessels.
The term ’angiogenesis’ is used, summarizing all different types of modifications of the arterial blood vessel growth.
All cells, whether they are the normal cells of the body, or abnormal ones, like the cancerous cells, need nutrition for their growth and development. The nutrition is in the form of rich supply of blood. The cells and the tumors are surrounded by a network of capillaries and blood vessels that feed these cells.
These fast growing cells promote angiogenesis. New blood vessels and capillaries form a complete network round the cells and tumors. These tumors and cells are able to receive a prompt supply of oxygenated blood that helps them to grow and metastasize.
The modern research is bent to investigate a slow down process to regulate, stop, or retard the process of angiogenesis. If this is done successfully, then there will be chances .that since the tumors will not be able to receive any blood supply, they will dry off.

Mesotherapy is a non-surgical procedure used for weight loss and body sculpting to reduce, eliminate and contour fat deposits and cellulite. It involves injecting small amounts of conventional or homeopathic medication and/or vitamins just under the skin surface (mesoderm) to break down the fatty tissue and improve skin circulation, tone, firmness and texture. It can also be used to rejuvenate the surface of the skin. The procedure can usually be carried out in 10 to 25 minutes with no recovery time involved. Prior to the procedure, the practitioner will identify and map the area to the treated. You will then lie on a therapy couch and the area will be swabbed with an antiseptic solution. The practitioner will then use tiny needles to inject the medication into the mesoderm. The ‘multi-pricking’ can be done by hand or by using a specific mechanical delivery system….. Read more…

Approximately 2,000 to 3,000 new cases of mesothelioma are diagnosed in the United States each year. Once a patient is diagnosed, a doctor will likely discuss their prognosis, or probable course and outcome of the cancer’s influence on the body. The best way to avoid a poor prognosis is through early detection. Mesothelioma is not generally diagnosed until the latest stages of development because of the amount of time it takes for patients to display symptoms associated with the disease. In addition to this, the symptoms of mesothelioma are very general and often resemble less serious conditions, which can make the cancer difficult to diagnose. As a result, the prognosis for the majority of patients is poor, but many doctors can recommend treatment options such as surgery, chemotherapy and radiation to help combat the disease.

Asbestos is a useful material made of six different fibrous minerals, namely: chrysotile, crocidolite, amosite, tremolite, anthophyllite, and actinolite. These asbestos minerals come from mines throughout the world, including mines in such locations as South America, Australia and Canada. Best known for its heat retardant capacity, asbestos is used in such products as roofing shingles, automobile brake pads, floor tiles, and assorted gaskets. Asbestos wraps were also commonly used over the years to insulate heating ducts and water pipes in homes, offices, and other buildings.
While asbestos has some outstanding benefits and is part of a number of useful products, it also has numerous hazardous aspects to it. Individuals exposed to asbestos fibers can suffer lung damage, heart damage, cancer, and other disabilities. Exposure to asbestos has also proven deadly. The negative aspects of asbestos have caused quite a stir since the 1960’s, when many of the problems associated with asbestos were discovered. Lawsuits seeking damages for asbestos-related disabilities and deaths have often been in the news….. Read more…

Mesothelioma is a relatively rare cancer, that is usually associated with asbestos. Exposure to asbestos fibers can cause mesothelioma even years later. Currently, mesothelioma is an active area of lawsuits and litigation. The area of law is not usually medical malpractice, because mesothelioma liability is usually related to the asbestos exposure, involving legal areas such as product liability, wrongful death, or other liability. However, medical malpractice for mesothelioma can occur due to failure to diagnose mesothelioma in its early stages. Such delayed diagnosis of mesothelioma worsens its prognosis. Always seek qualified legal advice about malpractice or other law, as the area is very complex

Initially, we extracted the numbers of mesothelioma cancer registrations and mesothelioma deaths nationally for 2004 from the Cancer Information System (CIS), which provides cancer registration and cancer mortality data from the whole of England. Thereafter, we extracted cancer registrations of patients diagnosed with mesothelioma in the South East of England area between 2000 and 2004 from the Thames Cancer Registry database. Patients who had cause of death specified on the death certificate were identified and used for the analysis. The deaths were classified hierarchically as follows: Firstly, we identified death certificates that mentioned mesothelioma as one of the causes of death. Secondly, among the remaining death certificates, we identified those that mentioned lung cancer as a cause of death. Third, among the now remaining death certificates, we identified those that mentioned an unspecified cancer as a cause of death. Last, there remained a group of death certificates that included no mention of mesothelioma, lung cancer or unspecified cancer….. Read more…

Mesothelioma is a rare form of cancer that arises from the pleura or, less often, from the peritoneum. The disease is almost always fatal and the median time between diagnosis and death is less than one year [1,2]. Mesothelioma is strongly associated with occupational exposure to asbestos fibres. Industries with high exposure to asbestos in the past included mining, shipyard working and asbestos cement manufacture. The annual numbers of mesothelioma deaths in Great Britain increased 12-fold in the period from 1968 to 2001[3] and an epidemiological model that incorporated the historical use of asbestos suggested that the annual numbers of deaths will continue to rise to a peak at around 1950–2400 deaths per year in 2011–2015. The aim of this analysis was to examine the certified causes of death of patients diagnosed with mesothelioma, and assess the validity of mortality data as a proxy for data on mesothelioma incidence.

Mesothelioma is not only a disease of adults, but this disease can, in rare cases, also strike children. Because the prognosis is poor, doctors need to carefully diagnose mesothelioma in their youngest patients. Doctors don’t know what causes mesothelioma in children. Although a high number of adults with the disease have a history of asbestos exposure, this isn’t the case in children. “The latent period of asbestos exposure in mesothelioma patients can be many years,” explains Cesar A. Moran, MD, professor of Pathology in the Department of Pathology at MD Anderson Cancer Center in Houston, Texas. “Children have not lived long enough to be in that ballpark.” Dr. Moran and his colleagues recently published a study in the journal, Histopathology, in which they looked at the cases of eight children with mesothelioma. All of the children had cancer in the abdominal cavity lining (peritoneal mesothelioma). Most adults with the disease have pleural mesothelioma, which affects the lining of the lung….. Read more…

Mesothelioma, if malignant, is an aggressive form of cancer caused by asbestos exposure. The asbestos that enters the body lodges itself within the lining the lungs, abdomen, heart, as well as other organs and eventually the problem takes an adverse shape and tumors form. The latency period of mesothelioma can be many years, so often diagnosing children with mesothelioma can be difficult because they have not lived that long. However there have been rare cases and studies that detected mesothelioma in children. Because the prognosis is poor, doctors need to carefully diagnose mesothelioma in their youngest patients. It is important to understand that mesothelioma is not inherited through genes, therefore just because your Mother or Father has it, does not mean it automatically is passed on. Mesothelioma is also not contagious. There have been cases where children have been diagnosed with mesothelioma but it is through contact with an asbestos exposure. Asbestos exposure can happen many different ways….. Read more…

For many years, asbestos was used in myriad industries and products because of its extraordinary heat- and fire-resistant properties. Because of that, it’s common to encounter asbestos in old homes or commercial buildings, where it may be found in the walls, floors, and ceilings. Anyone living in a home or working in a commercial location where asbestos is present should exercise great caution in dealing with the dangerous mineral

Many wonder what makes asbestos so dangerous. In fact, asbestos when it is in its whole, intact state is not at all dangerous. Damaged or “friable” asbestos, however, is a cause for concern. Friable asbestos is asbestos that has gotten old or has been in some way destroyed or damaged so that it now produces dangerous asbestos dust. The tiny fibers in the dust circulate throughout the air and may be inhaled by anyone in the vicinity. Unfortunately, the fibers are sharp and easily embed themselves in the lungs or mesothelium of those exposed, ventually causing scarring and perhaps cancer.

Mesothelioma is best described as a form of lung cancer that attacks the lining of the lungs, also known as the mesothelium. Though rare, this form of cancer is very aggressive and those who are diagnosed with the disease rarely survive beyond a year or two from the date of diagnosis. Many die within months, as the disease is generally not diagnosed until its later stages when treatment options are few. While individuals develop certain other cancers for a number of reasons, such as poor diet or stress, there is only one known cause of mesothelioma – exposure to asbestos. Doctors estimate that in more than 85% of all mesothelioma diagnoses, they can establish a definite link to asbestos.

Mesothelioma Heal and Treatment Options
What about treatment options for mesothelioma cancers? Mesothelioma is a rare cancer, which has a really long time period, as in the people body. Symptoms of the disease needs several years, from 30 to 50 years. As this disease, initial of a mesothelioma, cancer is really building complex.
Some other problem on sensing of mesothelioma, cancer is the similarity of the signals of the disease as signs of disease and other diseases. The diagnosis of mesothelioma is hard. Therefore, the diagnosis, this treat needs many dealings that must be fitted.
What is the treatment options for mesothelioma cancers? There are 3 options, primarily for treatment.
Operation option, the most powerful technique of treating cancer mesothelioma, taking away the affected fields and the closest part of the tumour surroundings. The surgeon could move out the full lung whenever really late.
Second adaptation of the chemotherapy, “a different option” for the treatment of tumours, letting a few patients to get certain types of chemicals affected in the blood and could defeat tumour cells. This option could be applied in conjunction with the possibility of surgery.

Mesothelioma: IntroductionMesothelioma is a relatively rare cancer, that is usually associated with asbestos. Exposure to asbestos fibers can cause mesothelioma even years later.
Currently, mesothelioma is an active area of lawsuits and litigation. The area of law is not usually medical malpractice, because mesothelioma liability is usually related to the asbestos exposure, involving legal areas such as product liability, wrongful death, or other liability. However, medical malpractice for mesothelioma can occur due to failure

Pericardial Mesothelioma diagnosis: Following these initial steps, a variety of imaging tests may be required to determine exactly where cancer is located. The final stage of diagnosis typically involves a biopsy to confirm the point of origin of the cancer. A biopsy involves the removal of tissue or fluid from the pericardium, followed by laboratory tests of the tissue and fluid to confirm the presence of mesothelioma. X-Rays, CT Scans, and biopsy’s are often used to help diagnose pericardial mesothelioma.
Treatment of Pericardial Mesothelioma: Treatment of pericardial mesothelioma is very difficult but it is always diagnosed in later stage. Surgery is possible to in early stage of pericardial mesothelioma to remove cancer cells. Palliative treatment is good for these patients. This type of treatment is performed to improve a patient's quality of life, and reduce the severity of symptoms caused by the build-up of fluid in the pericardium. Fine needle aspiration may be carried out to remove excess fluid as well. In some cases, radiation therapy may be an option. Unfortunately, the proximity of the heart and lungs make this a risky prospect.

Pericardial mesothelioma develops in the pericardium that covers and protects the heart. Some experts believe that during the inhalation of asbestos fibers into the lungs, some fibers through bloodstream may get stuck in the pericardium. After a long period of time, the asbestos fibers cause the cells of the pericardium to undergo changes that may result in cancer. Once cells become malignant it multiply rapidly, these malignant cells continue to grow and lead to pericardial thickening and eventually leads to development of tumor. Fluids starts accumulating in the pericardial membrane which, combined with the thickening of the layers, puts pressure on the heart.
Symptoms of Pericardial Mesothelioma: Pericardial mesothelioma is the rare cancer of all mesothelioma. It is very difficult to diagnose also, as their symptoms resembles with hear disease. A pericardial mesothelioma diagnosis may require a variety of tests to confirm the presence of cancer. Most symptoms of mesothelioma are caused by fluid in pericardium and thickening of pericardial layers.
These are the following symptoms of pericardial mesothelioma:
Difficulty breathing, even when at rest
Fever or night sweats
Heart palpitations or irregular heartbeat
Chest pain

Treatment

The type of treatment also typically relates to stage. For example in patients with stages I and II non-small cell lung cancer the treatment of choice is surgery. Radiation is often prescribed to patients with stage III disease or those with stages I or II for whom surgery is not performed. Radiation can provide relief of intrathoracic symptoms. Chemotherapy provides only modest survival benefits (1 to 2 months) in disseminated non-small cell lung cancer. The Cancer Monthly database currently has the results (survival, side effects, etc.) for 60 recent therapies for non-small-cell lung cancer including immunotherapy, chemotherapy, alternative therapy, surgery, and chemotherapy.

Type, Staging and Prognosis
Typical survival rates are related to type of lung cancer:
Type
Frequency
5-Year Survival Rate (All stages)
Small cell
18%
5%
Non-small cell:


Squamous or epidermoid carcinoma
29%
15%
Adenocarcinoma
32%
17%
Large cell carcinoma
9%
11%
In addition, typical survival rates are also related to stage. For example in non-small cell lung cancer there are five stages:
Stage
TNM
Description
5-year Survival Rate
I
T1-T2 N0 M0
T1 = tumor less than 3 cmT2 = tumor more than 3 cmN0 = no metastases to lymph nodeM0 = No known distant metastases
60-80%
II
T1-T2 N1 M0
N1 = Metastases in bronchopulmonary or ipsilateral hilar lymph nodesM0 = No known distant metastases
25-50%
IIIA
T3 N0-1 M0T1-3 N2 M0
T3 = Tumor extends into pleura, chest wall, diaphragm or pericardium
25-40%10-30%
IIIB
Any T4 or any N3 M0
T4 = Tumor invades mediastinum (i.e. heart, great vessels, trachea, esophagus, bone)
Less than 5%
IV
Any M1
M1 = Distant metastases
Less than 5%

Introduction
Lung cancer is the leading cause of cancer death in men and women. Every year, primary carcinoma of the lungs affects 93,000 men and 80,000 women in the U.S. and 86% die within 5 years of diagnosis. The incidence of lung cancer peaks between the ages 55 and 65.

The term lung cancer is for cancers arising from the respiratory epithelium (bronchi, bronchioles, and alveoli). Mesothelioma is distinct from epithelial lung cancer and are considered a different type of cancer.

There are two major subdivisions of lung cancer:

Small cell – sometimes called oat cell.
Non-small cell - comprised of various types including: - Squamous or epidermoid carcinoma
- Adenocarcinoma (including bronchioloalveolar)
- Large cell carcinoma (sometimes called large cell anaplastic)


Type, Staging and Prognosis

Mesothelioma
Mesothelioma disease is a form of severe cancer that is virtually always caused by a previous exposure to asbestos materials. In mesothelioma disease, malignant cells develop in the mesothelium which is a protective lining that is a covering of most of the body's internal organs.Its most common location is the pleura which is the outer lining of the lungs but it also occurs in the peritoneum whic is the lining of the abdominal cavity or the pericardium which is a sac that surrounds the heart.

What mesothelioma is
Mesothelioma is a type of cancer. It is a cancer of mesothelial cells. These cells cover the outer surface of most of our internal body organs, forming a lining that is sometimes called the mesothelium. So this is where this type of cancer gets its name.

Mesothelioma cancer can develop in the tissues covering the lungs or the abdomen.

Internal picture
Mesothelioma in the chest
Mesothelioma in the chestThe tissues lining (or covering) the lungs are called the pleura. There are two pleura. These can be called pleural membranes. The gap between them is called the pleural space. The pleura are fibrous sheets. They help to protect the lungs. They produce a lubricating fluid that fills the gap between the two pleura. This helps the lungs to move smoothly in the chest when they are inflating and deflating as we breathe. Mesothelioma is most often diagnosed in the pleura. This is known as pleural mesothelioma. Because it is so close, pleural mesothelioma can also affect the sheet of tissue covering the heart - the pericardium. Doctors call the pericardium the lining, although it is on the outside of the heart. It protects the heart and allows it to move smoothly within the sac that surrounds it. So it does much the same job for the heart as the pleura do for the lungs.
Mesothelioma in the abdomenThe tissue lining the abdomen (tummy) is called the peritoneum. It helps to protect the contents of the abdomen. It also produces a lubricating fluid. This helps the organs to move smoothly inside the abdomen as we move around.Mesothelioma of the tissues lining the abdominal cavity is known as peritoneal mesothelioma. It is much less common than pleural mesothelioma.It is unusual for mesothelioma to spread to other parts of the body. But if it does, it does not usually cause troublesome symptoms.
Benign mesotheliomaThere is a form of non cancerous (benign) mesothelioma that can develop in the lining of the lungs, or in the lining of the reproductive organs. It can occur in either men or women. These non cancerous tumours are very rare and we don't cover them in this section of CancerHelp UK.

Mesothelioma Prognosis
Typically the most important variable determining the prognosis and life expectancy of a mesothelioma patient is the stage of the cancer when it is diagnosed. Unfortunately, mesothelioma is more difficult to "stage" than other cancers. This is true for a couple of reasons: 1) because its somewhat rare, and 2) because its initial symptoms are subtle it is usually advanced when diagnosed, making it difficult to stage. Peritoneal mesothelioma in particular can be difficult to stage because, while pleural mesothelioma has multiple staging systems, pathologists still haven't developed a staging system for peritoneal mesothelioma. Both pleural and peritoneal types of mesothelioma are very serious conditions and neither have a good outlook.
Since mesothelioma is usually diagnosed at an advanced stage, the statistics for five year survival for early stage mesothelioma are usually unreliable. It also can not be said with certainty which of the two types is a worse diagnosis; peritoneal mesothelioma or pleural mesothelioma. Many studies show that peritoneal is a more deadly, and rapidly spreading mesothelioma than pleural mesothelioma, but these studies are often contradicted by specialists who argue pleural mesothelioma is the more dangerous and more difficult to treat of the two. Usually patients diagnosed with either peritoneal or pleural mesothelioma are told that they may have less than a year to live. However, according to researchers in leading research centers around the world this is not necessarily the case. More recent studies indicate that patients with mesothelioma might, in some instances, have a better out look than originally believed.
According to these studies about 10% of all people diagnosed with mesothelioma will be alive 3 years later and about 5% will be alive 5 years later. However, if the mesothelioma is detected in its earlier stages and treated, 50% will survive 2 years and 20% people will survive 5 years.
In one clinical trial involving 120 patients with different types of pleural mesothelioma, all of the patients underwent pleural pneumonectomies (removal of the lung and pleura), followed by radiotherapy and chemotherapy. 45 % were alive two years later and more than 20% were alive five years later.
In the same study, patients with sarcomatoid and mixed mesothelioma did not fare as well. Only 20% of these patients were alive two years later, and none of them survived five years.
However, patients that had no cancer in the lymph nodes and epithelioid type tumors did much better. Almost 75% survived longer than two years and nearly 40% were alive after five years

Mesothelioma Prognosis

Mesothelioma Prognosis
Approximately 2,000 to 3,000 new cases of mesothelioma are diagnosed in the United States each year. Once a patient is diagnosed, a doctor will likely discuss their prognosis, or probable course and outcome of the cancer’s influence on the body. The best way to avoid a poor prognosis is through early detection.
What Factors Affect Prognosis?
Mesothelioma is not generally diagnosed until the latest stages of development because of the amount of time it takes for patients to display symptoms associated with the disease. In addition to this, the symptoms of mesothelioma are very general and often resemble less serious conditions, which can make the cancer difficult to diagnose. As a result, the prognosis for the majority of patients is poor, but many doctors can recommend treatment options such as surgery, chemotherapy and radiation to help combat the disease.
Doctors typically address the cancer in terms of stages, ranging from stage one to stage four. Unfortunately, once mesothelioma cancer has reached stage three or four, treatment options not only become more limited but less effective as well. When a patient is diagnosed with stage four mesothelioma, their health condition often rules out the possibility of surgery. Treating mesothelioma becomes more difficult the later a diagnosis occurs.
Asbestos.com offers a complimentary packet containing information about treatment options and top doctors that may be able to help improve a patient’s prognosis. Click here to receive your packet overnight.
In addition to the stage of the cancer and the age of the patient, other factors that affect prognosis include:
The type of mesothelioma – pleural, peritoneal, pericardial or testicular
The size of the tumor
The location of the tumor and whether it can be surgically removed
The extent of other symptoms, including fluid in the lungs or abdomen
Whether or not the patient is a smoker

Malignant Mesothelioma Death Rate Chart

The graph featured in this image represents the amount of malignant mesothelioma deaths that occurred in the United States in 1999, organized by type. There are four different types of malignant mesothelioma, and two types, pleural mesothelioma and peritoneal mesothelioma are addressed in the graph. Patients may also be diagnosed with pericardial or testicular mesothelioma, although these forms of the cancer are very rare. Additional information about malignant mesothelioma, the various types of the cancer, symptoms and treatment options for patients diagnosed with mesothelioma may be found on the Malignant Mesothelioma page.

Mesothelioma Images, Diagrams, and Graphs

A diagram outlining the effects of asbestos on the body. Click the image to enlarge.

A diagram of the lung and its parts. Click the image to enlarge.

A diagram of the lung showing the effects of pleural mesothelioma. Click the image to enlarge.

A diagram of the abdomen showing where peritoneal mesothelioma occurs. Click the image to enlarge.

A diagram of the heart showing where pericardial mesothelioma occurs. Click the image to enlarge.

A chart showing malignant mesothelioma deaths. Click the image to enlarge.

A chart showing pleural mesothelioma susceptibility. Click the image to enlarge.

A chart showing mesothelioma survival rates. Click the image to enlarge.

A chart showing the combined effects of smoking and asbestos exposure. Click the image to enlarge.

An image of different types of malignant mesothelioma cells. Click the image to enlarge.

An overview of how cancer spreads at the cellular level. Click the image to enlarge.

A diagram of asbestos use in the home. Click the image to enlarge

Mesothelioma Immunohistochemistry

In general terms, immunohistochemistry (IHC) involves the process of locating proteins in tissue cells. The process uses staining to identify proteins, as well as the principle that antibodies bind to specific antigens in human tissue. Immunohistochemical staining is widely used in the diagnosis of cancerous cells and other abnormal cells. Mesothelioma immunohistochemistry is used to diagnose the histological type of a mesothelioma tumor, such as epithelial or sarcomatoid mesothelioma, which can effect treatment options.

Mesothelioma immunohistochemistry can be most useful in differentiating epithelial mesothelioma from other types of epithelial tumors. It has shown to be less effective for sarcomatoid mesotheliomas, but can be helpful when distinguishing sarcomatoid mesothelioma from sarcomatoid carcinoma.

Professionals in the field of mesothelioma note that immunohistochemistry data should be used in context with other diagnostic data. In other words, the results of a mesothelioma immunohistochemistry analysis should not be considered a primary indicator for a mesothelioma diagnosis. Contributing expert to the book Malignant Mesothelioma, Betta Peir-Giacomo, M.D. writes, "As for the capacity of IHC to provide possible clues to a more accurate diagnosis of MM (malignant mesothelioma), first it is necessary to underline that the contribution of IHC cannot be generalized, but differs in relation to each diagnostic setting, each with its own peculiar set of morphologic and immunophenotypic variables."

To learn more about the diagnostic process and treatment options available to mesothelioma patients, please fill out this form to receive an informative and complimentary packet in the mail.

Mesothelioma BerEP4

BerEP4 is a human antibody that can be expressed in epithelial cells. Antibodies, also known as "immunoglobulins," are specific proteins found in the blood which are used by the immune system to identify and neutralize foreign and unwanted objects, such as viruses and bacteria.

In the case of mesothelioma, BerEP4 has shown to be helpful in the diagnosis of epithelial mesotheliomas. However, immunohistochemists are still researching the efficacy of BerEP4 as a diagnostic indicator for mesothelioma, as this antibody has appeared both in mesotheliomas and other similar tumors. Thus, the presence or lack of BerEP4 does not always indicate a malignant mesothelioma

Mesothelioma Vimentin

Vimentin is a protein, more specifically a filament protein. Research has shown that vimentin proteins attach to the nucleus (and two other organelles) of a cell and help to anchor the position of the nucleus and other organelles. The dynamic structure of vimentin is important to the flexibility of a cell and it is generally accepted that this protein is important to maintaining cell integrity.

Like the antibody BerEP4, vimentin has shown to help diagnose mesothelioma, but the protein also appears in other tumors aside from mesotheliomas. Because vimentin appears in mesotheliomas as well as other malignant tumors, it is not considered a discriminatory marker for mesothelioma, but rather a piece of the diagnostic puzzle.

Mesothelioma Histology

Mesothelioma histology involves the anatomical study of mesothelioma cells, including sarcomatoid, desmoplastic (a variant of sarcomatoid), epithelial and biphasic cells. Scientists and medical professionals research and study mesothelioma cells to improve mesothelioma histopathology, which helps to diagnose mesothelioma through identifying anatomical structures of mesothelioma cells under a microscope.

Histology, Histopathology and Mesothelioma

Histology refers to the microscopic anatomical study of cells and tissues belonging to plants and animals. Sampled cells and tissues are observed under a microscope (a light or electron microscope) while the microscopic anatomy of the specimen is studied. A specimen must be "fixed" to preserve the sample from degradation. Fixing chemicals can include formaldehyde, glutaraldehyde, osmium tetroxide or uranyl acetate. The specimen is typically "stained" using a variety of chemicals, which allows histotechnicians to more clearly observe and study the sample.

Histopathology is the microscopic study of diseased cells and tissue in order to accurately diagnose cancer and other diseases. To diagnose various forms of cancer and disease a histopathologist examines a sample from a biopsy (an extracted specimen of the tumor being diagnosed) under a microscope and looks for anatomical indicators. A histopathologist diagnosing a malignant mesothelioma tumor will look for anatomical indicators on the tissue sample to designate whether the mesothelioma tumor is epithelial, sarcomatoid, desmoplastic or biphasic.

Mesothelioma Histology Types

Approximately 50 to 70 percent of malignant mesotheliomas are epithelial, around 20 to 35 percent are biphasic, and 7 to 20 percent are sarcomatoid. Epithelial cells are known for a well-defined and uniform shape. They can closely resemble cells of another form of cancer known as adenocarcinoma, which can complicate the diagnostic process for histopathologists. There are many subtypes of epithelial mesothelioma, such as tubulopapillary, microcystic and well-differentiated papillary mesotheliomas.

Sarcomatoid cells are known for their elongated spindle shape, which are typically irregular and not uniform in shape. These cells often overlap one another. Considered a variant of sarcomatoid mesothelioma, desmoplastic mesothelioma is sometimes considered the most difficult mesothelioma to diagnose. When a desmoplastic mesothelioma invades or spreads to other tissue, the cells tend to look very bland and this can lead to the mesothelioma being misdiagnosed as benign fibrous tissue. Mesothelioma experts agree that this form of mesothelioma should not be diagnosed with a needle core biopsy.

Mesothelioma cells that are biphasic contain both epithelial and sarcomatoid cells. These cells form in groups of similar cells and do not exhibit a uniform mixture. Because of this factor, several samples are collected from different locations within the tumor during a biopsy. This helps the histopathologist to accurately provide a mesothelioma diagnosis.

Considering the subtle differences that histopathologists must assess, diagnosing the type of mesothelioma can be difficult. A major contributing factor to this difficulty is the challenge in differentiating mesothelioma from adenocarcinoma (a cancer that originates in glandular tissue). Learning more about the diagnostic process can help mesothelioma patients to understand their condition and their treatment options. To learn more about mesothelioma histology, diagnosis and treatment options, please fill out this form to receive a complimentary packet in the mail.

Testing for Mesothelioma

Mesomark is an easily performed blood test that uses an enzyme-linked immunosorbent assay to measure the amount of Soluble Mesothelin-Related Peptides (SMRP) in human serum. SMRP is a biomarker that is produced by mesothelioma cells, and this biomarker may be elevated in the serum of patients who have mesothelioma. The detection of the biomarker through a blood test can help attain an early diagnosis, resulting in more treatment options and a better prognosis for patients.

Mesomark is what is referred to as an in-vitro test. In this test, the blood that is drawn from the patient is sent to a laboratory to measure the level of SMRP. This is performed by using monoclonal antibodies that are known to specifically bind to SMRP. Measuring the amount of bound antibodies in the blood indicates the amount of SMRP, and certain levels indicate the presence of mesothelioma.

In addition to detecting the presence of mesothelioma in yet-to-be-diagnosed patients, the Mesomark blood test may also be used to monitor the success of treatments in patients who have already been diagnosed with the disease. These tests will also help determine the next course of treatment.

Mesothelioma Blood Test

The reason for high death rates among mesothelioma patients is the aggressive nature of the disease and the inability to diagnose it until its latest stages. Because mesothelioma symptoms can remain dormant for up to 50 years, most cases at the time of diagnosis have already reached Stage III or IV. As a result, mesothelioma treatment options are often more palliative than curative.

However, the ability to diagnose the disease at an earlier time would certainly result in a better prognosis for mesothelioma patients. That ability is now present in the form of a mesothelioma blood test known as Mesomark. Developed by Fujirebio Diagnostics Inc. of Malvern, Pennsylvania, a leader in the field of oncology testing, the test measures the amount of a particular biomarker in human serum.

The test was first released in Australia in March 2005 and distribution expanded to Europe just a few months later. Food and Drug Administration approval for the blood test was received nearly two years later in January 2007.

Mesothelioma Support

No one should have to battle mesothelioma on their own. Anyone who has been diagnosed with this disease benefits from a large support network made up of family, friends, doctors, nurses, and others who truly care about the patient.

Malignant Mesothelioma Types

In biological terms, malignant mesothelioma is divided into four types: epithelial, sarcomatoid, biphasic and desmoplastic (a variant of sarcomatoid mesothelioma). These classifications pertain to the shape and structure of the cancer cells.

Diagram of Malignant Mesothelioma Types.

Between 50 to 70 percent of malignant mesothelioma cases are epithelial, approximately 20 to 35 percent are biphasic, and 7 to 20 percent are sarcomatoid. Epithelial cells are marked by their well-defined and uniform shape and can closely resemble cells of another form of cancer known as adenocarcinoma. Sarcomatoid cells display an elongated spindle shape, which tend to be irregular rather than uniform in shape, and the cells often overlap one another. Cells of the biphasic variety contain both epithelial and sarcomatoid cells, which form in groups of like cells rather than displaying a uniform mixture.

Diagnosing what type of malignant mesothelioma a patient has can be challenging. One contributing factor is that it can be difficult to differentiate mesothelioma from adenocarcinoma, a cancer originating in glandular tissue, on small tissue specimens.

Malignant Mesothelioma Causes

The only proven cause of malignant mesothelioma is asbestos exposure . Mesothelioma develops when asbestos fibers are inhaled or ingested and become lodged in the organs of the body. Overtime the fibers cause scarring and inflammation, which can eventually lead to the development of mesothelioma. The asbestos fibers cause cellular damage; resulting in the rapid division of cancers cells. The rapidly producing cells cause the affected membrane to thicken, resulting in fluid buildup in the spaces between the membrane layers. As the cells continue to divide and grow, tumors form. Unfortunately it typically takes between 20 and 50 years for a patient to demonstrate symptoms of mesothelioma, which frequently allows the cancer to progress to mature stages, making treatment more difficult.

Malignant Mesothelioma Symptoms

Patients with malignant mesothelioma generally do not display any symptoms until 20 to 50 years after exposure to asbestos occurs. This is due to the long latency period (the amount of time it takes for a patient to demonstrate symptoms after initial exposure to a disease-causing agent) associated with mesothelioma. The symptoms of mesothelioma are very general and often resemble less serious conditions, which can make diagnosis difficult.

Symptoms vary depending on the type of mesothelioma a patient has, but the most common symptoms expressed by pleural mesothelioma patients include shortness of breath, chest pain and persistent cough. Peritoneal mesothelioma patients may display symptoms such as abdominal swelling, changes in bowel movement and development of lumps under the skin on the abdomen. Patients with pericardial mesothelioma may experience heart palpitations, chest pain, difficulty breathing and fever or night sweats. Testicular mesothelioma patients may notice testicular lumps.

Asbestos.com offers a complimentary informational packet personalized to a patient’s specific mesothelioma diagnosis. With information about the cancer, treatment options and top doctors, many patients and their loved ones find the packet to be a valuable resource. Click here for more information or to receive your complimentary packet overnight.

Malignant Mesothelioma

Malignant mesothelioma is a form of asbestos cancer that affects the thin tissue layer surrounding the body's internal organs, called the mesothelium. The cancer is almost exclusively caused by asbestos exposure.

How Many and What Type of Malignant Mesothelioma Deaths Occurred in 1999.

Medical professionals divide malignant mesothelioma into various types depending on which area of the mesothelium is affected:

• Pleural mesothelioma is the most common form of the cancer, affecting the lining of the lungs, called the pleura.
• Peritoneal mesothelioma is the second most common form of the cancer and develops in the lining of the abdomen, called the peritoneum.
• Pericardial mesothelioma develops in the membrane that surrounds the heart, called the pericardium.
• Testicular mesothelioma is the rarest form of the cancer and develops in the membranous lining surrounding the testicles, called the tunica vaginalis.

How Does Asbestos Cause Peritoneal Mesothelioma?

There are two main theories regarding how asbestos exposure leads to the development of peritoneal mesothelioma:

• Asbestos fibers are ingested, and these fibers work their way from digestive organs into the peritoneal membrane.
• Asbestos fibers are inhaled, and travel to the peritoneal membrane via the lymphatic system.

Regardless of how asbestos fibers actually enter the peritoneal layers, once they do enter the membrane, the body experiences difficulty in expelling them. The fibers become trapped in the peritoneal membrane, and over a period of two or more decades, cause certain changes in the mesothelial cells of the peritoneum.

The exact way in which asbestos fibers cause changes in these mesothelial cells is uncertain. One theory is that asbestos fibers cause long-term inflammation and irritation that eventually causes mesothelial cells to become cancerous. When cells become cancerous, they lose the ability to regulate their own division and growth. Cancerous mesothelial cells divide and grow without restraint, and this uncontrolled cell growth causes thickening of the peritoneum, and the build-up of fluid in the peritoneal layers. Overtime, as cancerous cells continue to divide, tumors form.

With an assorted array of treatment options available to combat mesothelioma, it is important to understand your options and we offer a comprehensive packet with information about treatment and top doctors. To receive your packet, please fill out this form .

Peritoneal Mesothelioma Treatments

Though treating peritoneal mesothelioma can be difficult since the cancer has typically progressed to later stages of development, doctors typically recommend treatment to patients to combat the cancer and aid in pain relief. Common treatments used for patients with mesothelioma include surgery, chemotherapy and radiation . Chemotherapy medications and radiation therapy target and kill cancerous cells that rapidly divide.

While no known cure for peritoneal mesothelioma exists, patients may elect to undergo a combination of treatments or participate in clinical trials to alleviate pain and increase the quality of life. Clinical trials are studies that qualifying patients may participate to test up-and-coming medications and treatments. All potential treatment options and medications must go through clinical trials before they are deemed safe and effective.

Intraperitoneal chemotherapy is just one effective form of peritoneal mesothelioma treatment.

Some peritoneal mesothelioma patients may opt for intraperitoneal chemotherapy, where medications are injected directly into the peritoneum immediately following surgery. In some cases, patients may first go through radiation therapy to shrink tumors before undergoing surgery.

Many patients, however, are not good candidates for surgery since mesothelioma has often spread too extensively or because the patient’s general health is too poor to cope with the stress of surgery. These patients may elect to participate in palliative treatment options that do not attempt to cure a patient, but work to relieve symptoms and improve the quality of life for peritoneal mesothelioma patients.

Peritoneal Mesothelioma Diagnosis

X-rays are the most common scans used to help diagnose peritoneal mesothelioma.

A peritoneal mesothelioma diagnosis cannot be made on the basis of symptoms alone. The process begins with a thorough examination of a patient’s medical history and physical condition, followed by sophisticated diagnostic testing such as imaging and fluid and tissue tests.

Imaging tests such as x-rays or CT scans are used to detect any abnormalities in the body and a biopsy is usually performed to confirm that the cancer involved is indeed mesothelioma. A biopsy is a minor surgical procedure that involves the removal of fluid or tissue from the peritoneum.

After the biopsy, the fluid and tissue is tested in a laboratory for the presence of mesothelioma cells. If the biopsy returned reveals that a patient has peritoneal mesothelioma, the doctor, together with the patient, will detail a treatment plan.

Peritoneal Mesothelioma

Once asbestos is inhaled it can affect many of the body's different organs including the throat, lungs, stomach, heart and testicles.

Mesothelioma is a rare, aggressive cancer caused by asbestos exposure. Of the 2,000 to 3,000 cases of mesothelioma diagnosed in the United States annually, 10 to 20 percent of the patients are diagnosed with peritoneal mesothelioma. Peritoneal mesothelioma develops in the abdomen, in the mesothelial cells that form a membranous layer called the peritoneum.

The peritoneum is a membranous layer that is made up of two 'sub-layers' called the parietal and visceral layers. The parietal layer covers the abdominal cavity, while the visceral layer surrounds abdominal organs. Together these two layers provide support and protection for abdominal organs and the abdominal cavity as a whole.

Peritoneal mesothelioma, like all types of mesothelioma, is caused by asbestos exposure. Though it can take many years for a patient to demonstrate symptoms of peritoneal mesothelioma, the cancer develops when the asbestos fibers become lodged in the spaces between the mesothelial cells.

A peritoneal mesothelioma diagnosis can leave patients and their loved ones confused and questioning what to do next. We offer a complimentary packet for peritoneal mesothelioma patients containing information about their specific diagnosis, treatment options and top doctors. To receive this packet overnight, click here .

Pleural Mesothelioma Treatments

The on-going development of new drugs and detection techniques is improving the outlook for patients with pleural mesothelioma. Since pleural mesothelioma is the most common form of the cancer, more research and knowledge about this type of mesothelioma is present to utilize when detailing a treatment plan.

In general, pleural mesothelioma patients have three options: surgery, chemotherapy and radiation therapy. Typically, patients will receive a combination of two or more of these types of treatment.

Understanding available treatment options is often very important to patients and their loved ones. We offer a complimentary informational packet detailing treatment options for pleural mesothelioma patients. Click here to receive your packet overnight or call 800-615-2270 to speak with a patient and family advocate available at no charge to answer questions and offer guidance.

Early detection of pleural mesothelioma can improve a patient's mesothelioma prognosis considerably, and these patients have more extensive treatment options. If the disease is diagnosed early enough, surgery to remove localized tumors, followed by chemotherapy or radiation therapy to kill any remaining cancer cells can be an effective treatment. Curative surgery candidates must be in a good general state of health, and their cancer must not have spread beyond localized sections of the lungs.

When mesothelioma is diagnosed before the cancer has greatly progressed, a patient is typically in the first stages of mesothelioma. Doctors typically address the seriousness of cancer in terms of stages ranging from one to four, with the level of the cancer’s progression increasing with each stage. Patients diagnosed with pleural mesothelioma in stage one or two generally have greater treatment options and a better prognosis.

According to some current studies, approximately 10 percent of all pleural mesothelioma patients will survive for three to five years following diagnosis, and about 5 percent will survive five years or more.

Pleural mesothelioma patients who are not diagnosed early enough for curative treatment have fewer treatment options, mostly limited to palliative treatments, designed to relieve pain and discomfort to improve a patient's quality of life, rather than their prognosis. Palliative treatments include removal of built-up fluid from the pleural spaces, and surgical removal of tumors to relieve pressure on the lungs.

Pleural Mesothelioma Symptoms

Once trapped in the body, asbestos fibers cause cancerous cells to divide abnormally, resulting in the thickening of the pleural membrane layers and mesothelial cells, causing build-up of fluid (called pleural effusion). The fluid begins to put pressure on the lungs and the respiratory system in general, preventing normal breathing. Symptoms of pleural mesothelioma are largely caused by these developments and may include the following:

Pleural mesothelioma specifically develops in the pleural lining of the lungs.

• Persistent dry or raspy cough
• Coughing up blood (hemoptysis)
• Difficulty in swallowing (dysphagia)
• Shortness of breath that occurs even when at rest (dyspnea)
• Persistent pain in the chest or rib area, or painful breathing
• Development of lumps under the skin on the chest
• Night sweats or fever
• Unexplained weight loss
• Fatigue

Pleural Mesothelioma Diagnosis

As with other types of mesothelioma, pleural mesothelioma is difficult to diagnose since symptoms do not typically arise for some time after initial asbestos exposure occurs. Additionally, since the symptoms of pleural mesothelioma are typical of many illnesses, in the early stages of the cancer the symptoms are often mistaken for less threatening diseases such as influenza and pneumonia.

X-rays or CT-Scans are often used to diagnose pleural mesothelioma.

A pleural mesothelioma diagnosis is made partly on the basis of symptoms but additional diagnostic tests are needed to confirm the presence of cancer. Following a medical history review and physical examination, patients must typically undergo imaging tests, such as x-rays or CT scans, to confirm the location of cancer. A patient must also usually endure fluid and tissue tests, also known as biopsies, to confirm the type of cancer involved.

Mesothelioma Detection

Mesothelioma is almost exclusively caused by asbestos exposure. A patient is commonly diagnosed with the cancer 20 to 50 years after initial exposure to asbestos occurs since it may take decades for a patient to demonstrate symptoms of the disease. Mesothelioma is an aggressive cancer that can be difficult to treat and early mesothelioma detection can greatly help a patient’s prognosis.

Understanding mesothelioma symptoms may aid in early mesothelioma detection since a doctor should be contacted immediately at the first sign of any unusual developments. Many mesothelioma patients and their doctors are initially unaware of the severity of their condition as symptoms often resemble other common illnesses such as influenza or pneumonia.

Though there are four different types of mesothelioma, the most common form is pleural mesothelioma, which affects the lining of the lungs. Several symptoms demonstrated by pleural mesothelioma patients include persistent cough, difficulty breathing and swallowing, chest pain and fatigue.

Understanding that asbestos exposure can lead to the development of mesothelioma, and informing a doctor of asbestos exposure during a visit following unusual symptoms, can alert a doctor to the possibility of mesothelioma, aiding in early mesothelioma

What is mesothelioma?

Mesothelioma is a rare form of cancer in which cancerous cells are found in the mesothelium, a protective sac that covers most of the body's internal organs. There are two main types of mesothelioma - pleural which involves the sac that covers the pleural cavity around the lungs and peritoneal which involves the tissue that covers the abdominal area.

What causes mesothelioma?

The only accepted cause is exposure to asbestos. Asbestos was in thousands of different products so many people were exposed at many times in their lives.

How does one survive mesothelioma?

Treatment options include standard therapies (surgery and/or chemotherapy and/or radiation), clinical trials, and alternative or complimentary therapies. Despite the depressing information on the internet, there are long-term mesothelioma survivors including: Paul Kraus, Stephen Jay Gould, Rhio O'Connor, and others. Paul Kraus's book explains what he did to survive his mesothelioma.

New Directions for Treating Mesothelioma

Because conventional therapies are not curative for the overwhelming majority of mesothelioma patients, researchers are investigating new types of mesothelioma treatments and therapies. One approach that may yield promising results is anti-angiogenesis. Anti-angiogenesis is a form of therapy that uses drugs or other substances to stop tumors from making new blood vessels. Without a blood supply, the cancers cannot grow effectively. Today, there are several hundred clinical trials of anti-angiogenesis drugs under way. For example, Veglin is an anti-angiogenesis drug undergoing clinical trials at the University of Southern California's Keck School of Medicine. Under the supervision of Parkash S. Gill, M.D. and financed by grants from the Mesothelioma Research Foundation of America, a Phase I study of Veglin has demonstrated some success in patients suffering from lymphoma, sarcoma, and colon and lung cancers. Phase II studies are on-going with the hope they will demonstrate continued clinical efficacy in mesothelioma and other cancers